Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2)
1995 · Gastroenterology · 1,097 citations
https://doi.org/10.1016/0016-5085(95)90277-5
D
Daan W. Hommes
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
155
Papers
10.6K
Citations
45
h-index
72
i10-index
Daan W. Hommes is an academic researcher from University of California, Los Angeles. The author has contributed to research in topics: Inflammatory Bowel Disease & Microscopic Colitis & Helicobacter pylori-related gastroenterology studies. The author has an h-index of 45, co-authored 132 publications.
Papers by this author
worksThe London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD With the European Crohn's and Colitis Organization: When to Start, When to Stop, Which Drug to Choose, and How to Predict Response?
2010 · The American Journal of Gastroenterology · 407 citations
https://doi.org/10.1038/ajg.2010.392
Enhanced atherogenesis and altered high density lipoprotein in patients with Crohn's disease
2007 · Journal of Lipid Research · 89 citations
https://doi.org/10.1194/jlr.m700176-jlr200
MMP-2 and MMP-9 in normal mucosa are independently associated with outcome of colorectal cancer patients
2012 · British Journal of Cancer · 79 citations
https://doi.org/10.1038/bjc.2012.80
MMP-2 geno-phenotype is prognostic for colorectal cancer survival, whereas MMP-9 is not
2008 · British Journal of Cancer · 51 citations
https://doi.org/10.1038/sj.bjc.6604380
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat